# China NMPA Inspection - Guangxi Bama Laobagen Health Industry Co., Ltd. - September 16, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/guangxi-bama-laobagen-health-industry-co-ltd/dc5c2158-ef68-4692-b388-9f2b9165a9ad/
Source feed: China

> China NMPA unannounced inspection for Guangxi Bama Laobagen Health Industry Co., Ltd. published September 16, 2019. The Guangxi Zhuang Autonomous Region Drug Administration conducted unannounced inspections of two cosmetics manufacturers in August 2019 as part of it

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement of the Results of Supervision and Inspection of Cosmetic Manufacturers in Guangxi Zhuang Autonomous Region (Issue No. 7, 2019)
- Company Name: Guangxi Bama Laobagen Health Industry Co., Ltd.
- Publication Date: 2019-09-16
- Product Type: Cosmetics
- Summary: The Guangxi Zhuang Autonomous Region Drug Administration conducted unannounced inspections of two cosmetics manufacturers in August 2019 as part of its supervision work plan, based on the *Key Points for Cosmetic Production License Inspection*. 

Guangxi Bama Laobagen Health Industry Co., Ltd. was inspected on August 7, 2019. Significant deficiencies included the absence of environmental monitoring tools (thermometers, hygrometers) in production workshops, and improper storage conditions in raw material and finished product warehouses, exhibiting high humidity and inadequate separation from walls. Laboratory procedures were outdated, with uncalibrated equipment. Furthermore, the company failed to develop its own quality management documents, using inherited ones, and presented an incomplete organizational structure with unclear management responsibilities. The legal representative was observed issuing production instructions, indicating a lack of proper delegation.

On August 6, 2019, Guangxi Bama Impression Life Experience Industry Co., Ltd. was found to have multiple issues. These included a malfunctioning differential pressure gauge, incomplete labeling for hand sanitizer, and inappropriate storage of hazardous materials. Equipment maintenance records were missing, and the raw material and cosmetic warehouses suffered from high humidity, lack of environmental records, and disorganized storage. The product sample retention room was non-compliant, lacking proper environmental monitoring and sufficient sample retention. Crucially, there were no operational procedures for water treatment equipment, and the testing laboratory had unlabeled expired reagents and lacked equipment status indicators. Similar to the first company, management responsibilities for production and quality were not clearly defined.

Both companies were not in production during their respective inspections. As a result of these findings, the regulatory authority mandated that both enterprises rectify all identified issues within a specified timeframe and subsequently submit a detailed rectification report.

Company: https://www.globalkeysolutions.net/companies/guangxi-bama-laobagen-health-industry-co-ltd/5bd25269-ba5f-4a69-8c0c-36f858c8786f/